GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$16.39
+0.31%Institutional positioning
13F filings over the trailing two quarters
New 58Increased 0Reduced 0Sold out 58
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FLAGSHIP PIONEERING INC. | New Position | 62,673,117 | May 15, 2026 |
| FMR LLC | New Position | 4,217,524 | May 15, 2026 |
| CAPITAL WORLD INVESTORS | New Position | 4,004,149 | May 13, 2026 |
| BRAIDWELL LP | New Position | 3,592,999 | May 15, 2026 |
| JPMORGAN CHASE & CO | New Position | 2,947,259 | May 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | New Position | 2,109,633 | May 15, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | New Position | 1,944,426 | May 15, 2026 |
| HARBOURVEST PARTNERS LLC | New Position | 1,722,210 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | New Position | 1,423,602 | May 15, 2026 |
| HARVARD MANAGEMENT CO INC | New Position | 1,111,100 | May 15, 2026 |
| NVIDIA CORP | New Position | 833,325 | May 15, 2026 |
| SIREN, L.L.C. | New Position | 736,104 | May 14, 2026 |
| DAVERN CAPITAL PARTNERS, LP | New Position | 591,800 | May 14, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | New Position | 500,000 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | New Position | 498,408 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings